Brief: Epigenomics 9-Mth Net Loss Narrows To EUR -691,000

Epigenomics AG

10/11/2021 07:04

Nov 10 (Reuters) - EPIGENOMICS AG  ECXn.DE :
    * PUBLISHES FINANCIAL RESULTS FOR THE FIRST NINE MONTHS 2021
    * 9M NET LOSS -691,000 EUR VERSUS -9.109 MILLION EUR LOSS
YEAR AGO
    * 9-MONTH TOTAL REVENUE IN FIRST NINE MONTHS OF 2021
INCREASED TO
EUR 6,022 THOUSAND (9M 2020: EUR 541 THOUSAND)
    * 9-MONTH NET LOSS FOR PERIOD ALSO DECREASED SIGNIFICANTLY
TO EUR
-691 THOUSAND (9M 2020: EUR -9,109 THOUSAND)
    * 9-MONTH EBITDA IMPROVED SIGNIFICANTLY TO EUR -209 THOUSAND
IN
REPORTING PERIOD COMPARED TO EUR -8,090 THOUSAND
    * REVENUE AND EARNINGS GUIDANCE FOR FULL YEAR 2021 WAS
ADJUSTED ON
AUGUST 17, 2021
    * COMPANY EXPECTS REVENUES OF EUR 6.0 MILLION FOR FINANCIAL
YEAR
2021
    * OUTLOOK 2021: FOR EBITDA BEFORE SHARE-BASED PAYMENT COSTS,
EPIGENOMICS FORECASTS A RANGE OF EUR -3.0 MILLION TO EUR -4.0
MILLION FOR FULL YEAR 2021

Source text for Eikon:  ID:nEQ72q0WRa 
Further company coverage:  ECXn.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))